Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tonix-R is a botanical dietary supplement developed by LifeBiotic, formulated as a concentrated liquid hydro-alcoholic tincture. It contains a blend of seven medicinal mushrooms and plants: Reishi (*Ganoderma lucidum*), *Astragalus membranaceus*, *Wolfiporia extensa*, *Atractylodes macrocephala*, *Lycium chinense*, *Ligustrum lucidum*, and *Cordyceps sinensis*. The supplement is designed to modulate the immune system, specifically by enhancing the activity of Natural Killer (NK) cells and the vitality of neutrophils, which are key components of innate immunity. It is marketed as an adaptogen to promote vitality and combat fatigue, particularly in healthy individuals and oncology patients with compromised immune systems. Research conducted at Sheba Hospital has supported its immunomodulatory effects, showing benefits in both healthy and immunocompromised populations. Tonix-R is produced in the US and EU under FDA guidelines at cGMP-certified facilities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tonix-R.